Direct Capital, L.L.C.D. E.... Net Worth

Insiders trading at OrthoPediatrics corp

Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer, and Mark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.

What does OrthoPediatrics corp do?

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!

OrthoPediatrics corp executives and stock owners

OrthoPediatrics corp executives and other stock owners filed with the SEC include:

• Mark Throdahl,
  Chief Executive Officer, Director
• Fred Hite,
  Chief Financial Officer, Chief Operating Officer, Director
• Gregory Odle,
  Executive Vice President
• David Bailey,
  President
• Daniel Gerritzen,
  Vice President of Legal and Human Resources, General Counsel, Secretary
• Mark C. Throdahl,
  Exec. Chairman
• Fred L. Hite,
  CFO, Principal Financial & Accounting Officer, COO and Director
• David R. Bailey,
  Pres, CEO & Director
• Gregory A. Odle,
  Exec. VP of Commercialization
• Daniel J. Gerritzen,
  Gen. Counsel & Sec.
• Terry Schlotterback,
  Independent Chairman of the Board
• Marie Infante,
  Independent Director
• Bryan Hughes,
  Independent Director
• Kevin Unger,
  Independent Director
• Samuel Riccitelli,
  Independent Director
• Stephen Burns,
  Independent Director
• Bernie Berry,
  Independent Director
• Harald Ruf,
  Director
• David Pelizzon,
  Director
• Tram Bui,
  IR Contact Officer
• Paul J. Mraz,
  Sr. VP & GM of Scoliosis
• Mark Karshner,
  Sr. VP of International Sales
• Joe Hauser,
  Sr. VP & GM of Trauma & Deformity Correction
• Dr. Peter F. Armstrong M.D.,
  Chief Medical Officer & Chair of Surgeon Advisory Board
• Joel Batts,
  Sr. VP of Science & Technology
• Jennifer N. Pritzker,
  10% owner
• Frederick Hurley,
  Senior VP Merchandising
• Craig Kimbrough Currie,
  Senior VP My Twinn & BabyUnive
• Barry Hollingsworth,
  Chief Financial Officer
• John V. Schaefer,
  Director
• Edward John Ulbrich,
  Director
• Michael J. Wagner,
  Chief Executive Officer
• Christopher Cummings,
  Senior VP & CIO
• Pamela Nadine Abrams,
  Director
• Joseph Frank Rosales,
  Director
• Direct Capital, L.L.C.D. E....,
  
• John C Textor,
  Director
• E. Shaw Laminar Acquisition...,
  
• Harold Ruf,
  Director
• George Sinclair Mitchell Dyer,
  Director
• Joseph W Hauser,
  Pres. Trauma & Def. Correction
• Capital Llc Squadron Capita...,
  
• Jimmy Duane Mc Donald,
  Director